Apparent anaphylactoid reaction after treatment with a single dose of telithromycin.
BACKGROUND
Telithromycin, the first ketolide antimicrobial agent available in the United States, is related to the macrolide class of antibiotics. Reports of immediate-type hypersensitivity reactions with macrolides or ketolides are rare overall.


OBJECTIVE
To describe a patient with a severe, apparent mast cell-mediated reaction to telithromycin.


METHODS
A 54-year-old woman with a history of hypertension was prescribed telithromycin by her primary care physician for presumed bacterial sinusitis. Shortly after ingesting the first dose of telithromycin she developed severe shortness of breath, wheezing, and angioedema. Her allergic history was significant for the development of a maculopapular rash after taking sulfonamide antibiotics, but she had received erythromycin and azithromycin in the past with no adverse effects. She was intubated with difficulty and was treated with epinephrine, diphenhydramine, and corticosteroids. The patient made a full recovery.


RESULTS
Although not confirmed, the patient's severe symptoms were anaphylactoid and were ascribed to an immediate-type hypersensitivity reaction to telithromycin. No other causative agents, including other drugs, foods, and environmental exposures, were implicated in this case. Her history of tolerability to macrolide antibiotics is of interest considering the chemical similarities between these drugs and telithromycin.


CONCLUSIONS
To our knowledge, this is the first reported case of a severe, immediate-type hypersensitivity reaction to telithromycin. Physicians prescribing this drug should be aware of this rare but serious effect.
Bottenberg
Michelle M
MM
Department of Pharmacy, Iowa Methodist Medical Center, Des Moines, Iowa, USA.
Wall
Geoffrey C
GC
Hicklin
Greg A
GA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D017963:Azithromycin / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D048628:Ketolides / Q000009:adverse effects*; D018942:Macrolides / Q000627:therapeutic use; D008875:Middle Aged; D012852:Sinusitis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D048628:Ketolides; D018942:Macrolides; D017963:Azithromycin; D004155:Diphenhydramine; C106791:telithromycin; D004837:Epinephrine